Secukinumab in the treatment of psoriasis: patient selection and perspectives
Eric J Yang,1,2 Kristen M Beck,1 Wilson Liao1 1Department of Dermatology, University of California San Francisco, San Francisco, CA, USA; 2Chicago Medical School, Rosalind Franklin University of Medicine and Science, North Chicago, IL, USA Abstract: Secukinumab is a human monoclonal antibody targeti...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-10-01
|
Series: | Psoriasis : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/secukinumab-in-the-treatment-of-psoriasis-patient-selection-and-perspe-peer-reviewed-article-PTT |